Endocrinology

>

Latest News

Michael Haller, MD, discusses safety and use for inhaled insulin in T1D
Michael Haller, MD, discusses safety and use for inhaled insulin in T1D

August 18th 2025

Michael Haller, MD, discusses inhaled insulin’s safety, off-label use, and future role in easing type 1 diabetes management for children.

Richard Auchus, MD, on how crinecerfont is changing CAH treatment
Richard Auchus, MD, on how crinecerfont is changing CAH treatment

August 14th 2025

FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency | © Contemporary Pediatrics
FDA accepts NDA for ET-600, desmopressin oral solution for pediatric AVP deficiency

July 8th 2025

Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia | Image Credit: © lexiconimages - © lexiconimages - stock.adobe.com.
Positive data: Navepegritide, lonapegsomatropin combination treatment for children with achondroplasia

June 9th 2025

FDA accepts navepegritide application to treat children with achondroplasia | Image credit: Contemporary Pediatrics
FDA accepts navepegritide application to treat children with achondroplasia

June 2nd 2025

Video Interviews
Podcasts
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.